These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27912200)

  • 21. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism.
    Lin YS; Tsai HY; Lin CY; Wu VC; Chen TH; Yang TY; Aboyans V; Chen MC
    Glob Heart; 2021 Jun; 16(1):45. PubMed ID: 34211831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage mechanical dispersion provides incremental value for thromboembolic risk stratification over CHA
    Mao Y; Ma M; Yang Y; Yu C; Wang Y; Jiang R; Jiang C
    Int J Cardiol; 2020 May; 307():41-47. PubMed ID: 32089322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: role of transesophageal echocardiography and multidetector computed tomography.
    Dorenkamp M; Sohns C; Vollmann D; Lüthje L; Seegers J; Wachter R; Puls M; Staab W; Lotz J; Zabel M
    Int J Cardiol; 2013 Feb; 163(1):26-33. PubMed ID: 21764466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of left atrial thrombus by intracardiac echocardiography in patients undergoing ablation of atrial fibrillation.
    Sriram CS; Banchs JE; Moukabary T; Moradkhan R; Gonzalez MD
    J Interv Card Electrophysiol; 2015 Sep; 43(3):227-36. PubMed ID: 25935227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Kidney Disease as a Possible Predictor of Left Atrial Thrombogenic Milieu Among Patients with Nonvalvular Atrial Fibrillation.
    Kizawa S; Ito T; Akamatsu K; Ichihara N; Nogi S; Miyamura M; Kanzaki Y; Sohmiya K; Hoshiga M
    Am J Cardiol; 2018 Dec; 122(12):2062-2067. PubMed ID: 30293657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of inappropriate anticoagulation in patients with a CHA
    Saberian S; Badin A; Siebert V; Roy A; Banga S; Ghadiam HR; Wigant RR; Aggarwal A; Baman TS
    Int J Cardiol; 2017 Dec; 248():179-181. PubMed ID: 28807511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.
    Chan YH; Wu LS; Chang SH; Lee HF; Liu JR; See LC; Yeh YH; Kuo CT
    PLoS One; 2016; 11(3):e0151485. PubMed ID: 26986069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the CHADS2 and CHA2DS2-VASc Scores.
    Kim MN; Kim SA; Choi JI; Park SM; Park SW; Kim YH; Shim WJ
    Int Heart J; 2015 May; 56(3):286-92. PubMed ID: 25912904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial spontaneous echo contrast occurring in patients with low CHADS
    Akamatsu K; Ito T; Ozeki M; Miyamura M; Sohmiya K; Hoshiga M
    Cardiovasc Ultrasound; 2020 Aug; 18(1):31. PubMed ID: 32738924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical characteristics of left atrial appendage thrombus in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Ruan YF; Ning M; Hu R; Lyu J; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):956-962. PubMed ID: 31877590
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score.
    Yao Y; Shang MS; Gao LJ; Zhao JH; Yang XH; Liu T; Tang RB; Jiang CX; Long DY; Ning M; Zhu H; Lv Q; Hu R; Du X; Dong JZ
    Europace; 2018 Jul; 20(7):1093-1098. PubMed ID: 28637244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?
    Alyeshmerni D; Pirmohamed A; Barac A; Smirniotopoulos J; Xue E; Goldstein S; Mazel J; Lindsay J
    J Am Soc Echocardiogr; 2013 Sep; 26(9):1099-105. PubMed ID: 23850522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left atrial appendage flow velocity after successful ablation of persistent atrial fibrillation: clinical perspective from transesophageal echocardiographic assessment during sinus rhythm.
    Kusa S; Komatsu Y; Taniguchi H; Uchiyama T; Takagi T; Nakamura H; Miyazaki S; Hachiya H; Iesaka Y
    Am Heart J; 2015 Feb; 169(2):211-21. PubMed ID: 25641530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Left Atrial Thrombi and Spontaneous Echocardiographic Contrast in the Acute Phase After Cardioembolic Stroke in Patients With Atrial Fibrillation.
    Kishima H; Mine T; Fukuhara E; Ashida K; Uchida K; Yoshimura S; Ishihara M
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1571-1577. PubMed ID: 30930240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
    Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
    Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.